Yang Xi, Li Hongfeng, Sun Huahui, Fan Hongxia, Hu Yaqi, Liu Min, Li Xin, Tang Hua
Tianjin Life Science Research Center and Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
Tianjin Life Science Research Center and Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.01919-16. Print 2017 May 15.
MicroRNAs (miRNAs) are a class of small, single-stranded, noncoding, functional RNAs. Hepatitis B virus (HBV) is an enveloped DNA virus with virions and subviral forms of particles that lack a core. It was not known whether HBV encodes miRNAs. Here, we identified an HBV-encoded miRNA (called HBV-miR-3) by deep sequencing and Northern blotting. HBV-miR-3 is located at nucleotides (nt) 373 to 393 of the HBV genome and was generated from 3.5-kb, 2.4-kb, and 2.1-kb HBV in a classic miRNA biogenesis (Drosha-Dicer-dependent) manner. HBV-miR-3 was highly expressed in hepatoma cell lines with an integrated HBV genome and HBV hepatoma tumors. In patients with HBV infection, HBV-miR-3 was released into the circulation by exosomes and HBV virions, and HBV-miR-3 expression had a positive correlation with HBV titers in the sera of patients in the acute phase of HBV infection. More interestingly, we found that HBV-miR-3 represses HBsAg, HBeAg, and replication of HBV. HBV-miR-3 targets the unique site of the HBV 3.5-kb transcript to specifically reduce HBc protein expression, levels of pregenomic RNA (pgRNA), and HBV replication intermediate (HBV-RI) generation but does not affect the HBV DNA polymerase level, thus suppressing HBV virion production (replication). This may explain the low levels of HBV virion generation with abundant subviral particles lacking core during HBV replication, which may contribute to the development of persistent infection in patients. Taken together, our findings shed light on novel mechanisms by which HBV-encoded miRNA controls the process of self-replication by regulating HBV transcript during infection. Hepatitis B is a liver infection caused by the hepatitis B virus (HBV) that can become a long-term, chronic infection and lead to cirrhosis or liver cancer. HBV is a small DNA virus that belongs to the hepadnavirus family, with virions and subviral forms of particles that lack a core. MicroRNA (miRNA), a small (∼22-nt) noncoding RNA, was recently found to be an important regulator of gene expression. We found that HBV encodes miRNA (HBV-miR-3). More importantly, we revealed that HBV-miR-3 targets its transcripts to attenuate HBV replication. This may contribute to explaining how HBV infection leads to mild damage in liver cells and the subsequent establishment/maintenance of persistent infection. Our findings highlight a mechanism by which HBV-encoded miRNA controls the process of self-replication by regulating the virus itself during infection and might provide new biomarkers for diagnosis and treatment of hepatitis B.
微小RNA(miRNA)是一类小的、单链的、非编码的功能性RNA。乙型肝炎病毒(HBV)是一种有包膜的DNA病毒,其病毒粒子和亚病毒形式的颗粒缺乏核心。此前尚不清楚HBV是否编码miRNA。在此,我们通过深度测序和Northern印迹法鉴定出一种HBV编码的miRNA(称为HBV-miR-3)。HBV-miR-3位于HBV基因组的核苷酸(nt)373至393处,以经典的miRNA生物合成(依赖Drosha-Dicer)方式由3.5 kb、2.4 kb和2.1 kb的HBV产生。HBV-miR-3在整合了HBV基因组的肝癌细胞系和HBV肝癌肿瘤中高度表达。在HBV感染患者中,HBV-miR-3通过外泌体和HBV病毒粒子释放到循环中,并且HBV-miR-3的表达与HBV感染急性期患者血清中的HBV滴度呈正相关。更有趣的是,我们发现HBV-miR-3抑制HBsAg、HBeAg以及HBV的复制。HBV-miR-3靶向HBV 3.5 kb转录本的独特位点,以特异性降低HBc蛋白表达、前基因组RNA(pgRNA)水平以及HBV复制中间体(HBV-RI)的产生,但不影响HBV DNA聚合酶水平,从而抑制HBV病毒粒子的产生(复制)。这可能解释了在HBV复制过程中,尽管有大量缺乏核心的亚病毒颗粒,但HBV病毒粒子产生水平较低的现象,这可能有助于患者持续性感染的发展。综上所述,我们的研究结果揭示了HBV编码的miRNA在感染过程中通过调节HBV转录本来控制自身复制过程的新机制。乙型肝炎是由乙型肝炎病毒(HBV)引起的肝脏感染,可发展为长期的慢性感染,并导致肝硬化或肝癌。HBV是一种小DNA病毒,属于嗜肝DNA病毒科,其病毒粒子和亚病毒形式的颗粒缺乏核心。微小RNA(miRNA)是一种小的(约22 nt)非编码RNA,最近被发现是基因表达的重要调节因子。我们发现HBV编码miRNA(HBV-miR-3)。更重要的是,我们揭示了HBV-miR-3靶向其转录本以减弱HBV复制。这可能有助于解释HBV感染如何导致肝细胞轻度损伤以及随后持续性感染的建立/维持。我们的研究结果突出了HBV编码的miRNA在感染过程中通过调节病毒自身来控制自我复制过程的机制,并可能为乙型肝炎的诊断和治疗提供新的生物标志物。